Latest Benign Prostatic Hyperplasia (BPH) News
Procedure partially blocks blood flow to the gland and appears to ease the need to urinate.
Three quarters of patients experienced significant improvements in lower urinary tract symptoms and quality of life observed and were satisfied with treatment.
Prostatic arterial embolization significantly reduced volumes of median lobes, central zones, peripheral zones, and whole prostate glands.
Men receiving common medical treatments for LUTS/BPH, including phytotherapy, experienced similar symptom relief.
The risk is 67% higher in men with a prostate size of 40.1-80 mL than those with smaller glands.
The risk of bladder outlet obstruction increased 34% per unit increase in serum PSA and decreased 23% per unit increase in maximal flow rate.
A recent review found little evidence to support severe lower urinary tract symptoms as a contraindication to TRT.
More adverse events seen when people undergoing interventional radiology have negative attitude.
Previous studies may have overlooked the placebo effect.
Use of high-velocity saline streams show promise in a small, first-in-man study.
Review shows significant change in symptom scores, maximum urinary flow in sham surgery arm
Age, obesity promote methylation, suppression of 5-reductase 2
Increasing thickness was associated with increasing number of poor indicators for bladder outlet obstruction in men with enlarged prostates.
CAM associated with polypharmacy, vision impairment, and urologic comorbidities.
The malignancy is 36% less likely to develop, after adjusting for age and smoking, data show.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)